TerminatedNot Applicable

Incidence of Respiratory Depression in Cesarean Section

Stopped: departmental financial support withdrawn

United States100 participantsStarted 2010-07

Plain-language summary

This study is designed to determine the incidence and severity of respiratory depression in elective cesarean section patients who have received a spinal or epidural narcotic called duramorph for management of postoperative pain. A monitoring device called a capnograph as well as a device called a pulse oximeter is placed on the patient once in the recovery room after delivery. The capnograph monitors the carbon dioxide level that the patient breathes out as well as their respiratory rate. The pulse oximeter is a device that is taped on the patient's finger and measures their oxygen saturation level. The monitoring is maintained for 18-24 hours after surgery.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Are female \>= 18 years of age and \<=55 years of age with ASA class I-III * Schedule for cesarean surgery * Are willing and able to sign informed consent form for this study * Are willing and able to follow the instruction in this study protocol Exclusion Criteria: * Have known contraindication/allergy to neuraxial anesthesia or morphine. * Have an ASA class \> III * Age \> 55 years

What they're measuring

RESPIRATORY DEPRESSION

Timeframe: 24 HOURS

Trial details

NCT IDNCT01181843

SponsorWake Forest University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-06

View on ClinicalTrials.gov More Respiratory Depression trials